The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Open accessAbstract
Objective: To examine interactions of apolipoprotein E ( APOE) genotype with age and with in vivo measures of preclinical Alzheimer disease (AD) in cognitively normal aging. Methods: Two hundred forty‐one cognitively normal individuals, aged 45–88 years, had cerebral amyloid imaging studies with Pittsburgh Compound‐B (PIB). Of the 241 individuals, 168 (70%) also had cerebrospinal fluid (CSF) assays of amyloid‐beta 42 (Aβ 42 ), tau, and phosphorylated tau (ptau 181 ). All individuals were genotyped for APOE . Results: The frequency of individuals with elevated mean cortical binding potential (MCBP) for PIB rose in an age‐dependent manner from 0% at ages 45–49 years to 30.3% at 80–88 years. Reduced levels of CSF Aβ 42 appeared to begin earlier (18.2% of those aged 45–49 years) and increase with age in higher frequencies (50% at age 80–88 years) than elevations of MCBP. There was a gene dose effect for the APOE4 genotype, with greater MCBP increases and greater reductions in CSF Aβ 42 with increased numbers of APOE4 alleles. Individuals with an APOE2 allele had no increase in MCBP with age and had higher CSF Aβ 42 levels than individuals without an APOE2 allele. There was no APOE4 or APOE2 effect on CSF tau or ptau 181 . Interpretation: Increasing cerebral Aβ deposition with age is the pathobiological phenotype of APOE4 . The biomarker sequence that detects Aβ deposition may first be lowered CSF Aβ 42 , followed by elevated MCBP for PIB. A substantial proportion of cognitively normal individuals have presumptive preclinical AD. ANN NEUROL 2010;67:122–131
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The association of the APOE4 isoform with amyloid deposition has been well established in human studies, where APOE4 carriers exhibit higher A β plaque burden and earlier onset of amyloid positivity compared with non-carriers 35 -37 .”
From APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE status has been found to modulate the onset of extracellular amyloid plaque deposition, one of the key pathognomonic features of the disease (6, 7).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“On the basis of previous studies (7, 27), individuals with mean cortical binding potential (MCBP) for PIB >0.18 were considered PIB-positive (PIB+).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Given that a CSF Aβ42 concentration lower than 500 pg/mL has been utilized as a reliable threshold for the presence of cerebral Aβ deposition in humans (7, 19, 22, 26)”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Increasing age and ApoE genetic background are the strongest known risk factors for AD and plaque load (33, 48); thus it was critical that these parameters were controlled.”
From Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans (2011) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“Sex differences in Aβ burden alone have not been reported in older adults,11–13”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [13]
In the citing paper
“Previous cross-sectional studies indicate that Aβ42 levels decrease in the CSF as Aβ starts to accumulate, before fibrillar plaques can be detected with PET7–11.”
From Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,345
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Flagged first, then by citations
1 of the 80 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 835
Bonifacio, G., & Zamboni, G. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133759 · Cited by 41
Pettigrew, C., Soldan, A., Moghekar, A., Wang, M.-C., Gross, A. L., O’Brien, R., & Albert, M. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.09.024 · Cited by 38
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases
Campbell, M. C., Markham, J., Flores, H. P., Hartlein, J. M., Goate, A., Cairns, N. J., Videen, T. O., & Perlmutter, J. S. (2013) · Neurology · doi:10.1212/wnl.0b013e31829e6f94 · Cited by 39
Self-citationMcMillan, C. T., & Wolk, D. A. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312690 · Cited by 39
Wirth, M., Bejanin, A., Joie, R. L., Arenaza‐Urquijo, E. M., Gonneaud, J., Landeau, B., Perrotin, A., Mézenge, F., Sayette, V. D. L., Desgranges, B., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.023 · Cited by 40
Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
Ahmadian, N., Hejazi, S., Mahmoudi, J., & Talebi, M. (2018) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.5.307 · Cited by 42
Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease
Pasqualetti, G., Thayanandan, T., & Edison, P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101723 · Cited by 39
Alzheimer’s Disease: A Systems View Provides a Unifying Explanation of Its Development
Grobler, C., van Tongeren, M., Gettemans, J., Kell, D. B., & Pretorius, E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220720 · Cited by 45
More than just risk for Alzheimer’s disease: APOE ε4's impact on the aging brain
Palmer, J. M., Huentelman, M. J., & Ryan, L. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.06.003 · Cited by 39
APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus
Pyykkö, O. T., Helisalmi, S., Koivisto, A. M., Mölsä, J. A. A., Rummukainen, J. K., Nerg, O., Alafuzoff, I. I., Savolainen, S., Soininen, H. S., Jääskeläinen, J. E., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-303849 · Cited by 38
Mecca, A. P., Barcelos, N. M., Wang, S., Brück, A., Nabulsi, N., Planeta‐Wilson, B., Nadelmann, J. B., Benincasa, A. L., Ropchan, J. R., Huang, Y. H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.027 · Cited by 40
Thirunavu, V. M., McCullough, A. A., Su, Y., Flores, S. E., Dincer, A., Morris, J. C., Cruchaga, C., Benzinger, T. L. S., & Gordon, B. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190154 · Cited by 37
Self-citationTardif, C. L., Devenyi, G. A., Amaral, R. S. C., Pelleïeux, S., Poirier, J., Rosa‐Neto, P., Breitner, J. C. S., & Chakravarty, M. M. (2017) · Human Brain Mapping · doi:10.1002/hbm.23897 · Cited by 36
Kagerer, S. M., Bergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Studer, S. T., Treyer, V., Meyer, R., Kaufmann, P. A., Nitsch, R. M., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12002 · Cited by 37
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
Henson, R. L., Doran, E. W., Christian, B. T., Handen, B. L., Klunk, W. E., Lai, F., Lee, J. H., Rosas, H. D., Schupf, N., Zaman, S. H., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12057 · Cited by 34
Self-citationJablonski, A. M., Warren, L., Usenovic, M., Zhou, H. H., Sugam, J. A., Parmentier‐Batteur, S., & Voleti, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-82901-1 · Cited by 38
Sojkova, J., & Resnick, S. M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745375 · Cited by 36
Physical Activity and Cognitive Trajectories in Cognitively Normal Adults
Pizzie, R. G., Hindman, H., Roe, C. M., Head, D. M., Grant, E., Morris, J. C., & Hassenstab, J. J. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31829628d4 · Cited by 37
Self-citationOlive, C., Ibanez, L., Farias, F. H. G., Wang, F., Budde, J. P., Norton, J. B., Gentsch, J., Morris, J. C., Li, Z., Dube, U., et al. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-200019 · Cited by 32
Self-citationAmyloid PET Quantification Via End-to-End Training of a Deep Learning
Initiative, A. D. N., Kim, J. Y., Suh, H. Y., Ryoo, H. G., Oh, D., Choi, H., Paeng, J. C., Cheon, G. J., Kang, K. W., & Lee, D. S. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00610-0 · Cited by 34
Minimal Atrophy of the Entorhinal Cortex and Hippocampus: Progression of Cognitive Impairment
Varón, D., Loewenstein, D., Potter, E., Greig, M. T., Agrón, J., Shen, Q., Zhao, W., Ramirez, M. C. M., Santos, I., Barker, W., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000324711 · Cited by 36
Yu, M., Risacher, S. L., Nho, K. T., Wen, Q., Oblak, A. L., Unverzagt, F. W., Apostolova, L. G., Farlow, M. R., Brosch, J. R., Clark, D. G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113691 · Cited by 36
Wallon, D., Rovelet‐Lecrux, A., Deramecourt, V., Pariente, J., Auriacombe, S., Ber, I. L., Schraen‐Maschke, S., Pasquier, F., Campion, D., & Hannequin, D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120877 · Cited by 34
The prognostic value of amyloid imaging
Gelosa, G., & Brooks, D. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2108-x · Cited by 35
Lesser, G. T., Beeri, M. S., Schmeidler, J., Purohit, D. P., & Haroutunian, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563755 · Cited by 37
Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier
Asih, P. R., Tegg, M., Sohrabi, H. R., Carruthers, M. E., Gandy, S., Saad, F., Verdile, G., Ittner, L. M., & Martins, R. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161259 · Cited by 34
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Dincer, A., Chen, C. D., McKay, N. S., Koenig, L. N., McCullough, A. A., Flores, S. E., Keefe, S., Schultz, S. A., Feldman, R. L., Joseph‐Mathurin, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7646 · Cited by 34
Self-citationCholesterol Balance in Prion Diseases and Alzheimer’s Disease
Hannaoui, S., Shim, S. Y., Cheng, Y. C., Corda, E., & Gilch, S. (2014) · Viruses · doi:10.3390/v6114505 · Cited by 36
DeCarli, C. S., Villeneuve, S., Maillard, P., Harvey, D. J., Singh, B., Carmichael, O. T., Fletcher, E. M., Olichney, J., Farias, S. T., Jagust, W. J., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180965 · Cited by 33
Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins
Strickland, M. R., Rau, M. J., Summers, B., Basore, K., Wulf, J., Jiang, H., Chen, Y., Ulrich, J. D., Randolph, G. J., Zhang, R., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.018 · Cited by 28
Self-citationComparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis
Fu, L., Liu, L., Zhang, J., Xu, B., Yong Fan, A., & Tian, J. (2014) · European Radiology · doi:10.1007/s00330-014-3311-x · Cited by 35
Longitudinal change in working memory as a function of APOE genotype in midlife and old age
Greenwood, P. M., Espeseth, T., Lin, M., Reinvang, I., & Parasuraman, R. (2014) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12123 · Cited by 37
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
Lautner, R., Insel, P. S., Skillbäck, T. B., Olsson, B., Landén, M., Frisoni, G. B., Herukka, S., Hampel, H. J., Wallin, A., Minthon, L., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0313-3 · Cited by 34
Suzuki, K., Hirakawa, A., Ihara, R., Iwata, A., Ishii, K., Ikeuchi, T., Sun, C., Donohue, M., Iwatsubo, T., & Alzheimer's Disease Neuroimaging Initiative, J. A. D. N. I. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12007 · Cited by 32
Kim, J.-Y., Oh, D., Sung, K., Choi, H., Paeng, J. C., Cheon, G. J., Kang, K. W., Lee, D. Y., & Lee, D. S. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05044-x · Cited by 33
Wang, Y., Pan, F., Xie, F., He, R., & Guo, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.820385 · Cited by 33
Amyloid imaging and memory change for prediction of cognitive impairment
Resnick, S. M., & Sojkova, J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt62 · Cited by 33
A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment
Xie, L., Dolui, S., Das, S. R., Stockbower, G. E., Daffner, M., Rao, H., Yushkevich, P. A., Detre, J. A., & Wolk, D. A. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.03.002 · Cited by 34
Diagnosing early cognitive decline—When, how and for whom?
Allan, C. L., Behrman, S., Ebmeier, K. P., & Valkanova, V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.11.018 · Cited by 32
Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers
Korthauer, L. E., Zhan, L., Ajilore, O., Leow, A., & Driscoll, I. F. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.052 · Cited by 31
Lee, J., Ahn, S.-Y., Lee, H. A., Won, K. S., Chang, H. W., Oh, J. S., & Kim, H. W. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1415 · Cited by 32
Aschenbrenner, A. J., Hassenstab, J. J., Morris, J. C., Cruchaga, C., & Jackson, J. J. (2023) · Neuropsychology · doi:10.1037/neu0000905 · Cited by 32
Self-citationNeuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
Chételat, G., & Fouquet, M. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.025 · Cited by 32
Pereira, J. B., Strandberg, T. O., Palmqvist, S., Volpe, G., van Westen, D., Westman, E., Hansson, O., & Initiative, A. D. N. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx294 · Cited by 33
β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies
Diaz‐Galvan, P., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Senjem, M. L., Gunter, J. L., Jack, C. R., Min, H.-K. P., Jain, M., Miyagawa, T., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207393 · Cited by 31
Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities
Nebes, R. D., Snitz, B. E., Cohen, A. D., Aizenstein, H. J., Saxton, J. A., Halligan, E. M., Mathis, C. A., Price, J. C., Kamboh, M. I., Weissfeld, L. A., et al. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.07.017 · Cited by 32
Galle, S. A., van der Spek, A., Drent, M. L., Brugts, M. P., Scherder, E., Janssen, J. A. M. J. L., Ikram, M. A., & van Duijn, C. M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00020 · Cited by 30
Biomarkers in Alzheimer’s Disease
Riverol, M., & López, O. L. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00046 · Cited by 33
Impact of brain aging and neurodegeneration on cognition
Draganski, B., Lutti, A., & Kherif, F. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000029 · Cited by 32
Aschenbrenner, A. J., Balota, D. A., Tse, C., Fagan, A. M., Holtzman, D. M., Benzinger, T. L. S., & Morris, J. C. (2014) · Neuropsychology · doi:10.1037/neu0000133 · Cited by 32
Self-citationNemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., Joie, R. L., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T., Nudelman, K. N. H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13403 · Cited by 32
Wijesinghe, P., Shankar, S. K., Yasha, T. C., Gorrie, C. A., Amaratunga, D., Hulathduwa, S., Kumara, K. S., Samarasinghe, K., Suh, Y., Steinbusch, H. W. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160425 · Cited by 30
Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories
Lopresti, B. J., Campbell, E. M., Yu, Z., Anderson, S., Cohen, A. D., Minhas, D. S., Snitz, B. E., Royse, S. K., Becker, C. R., Aizenstein, H. J., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.05.012 · Cited by 32
Benson, G. S., Bauer, C., Hausner, L., Couturier, S. P., Lewczuk, P., Peters, O., Hüll, M., Jahn, H., Jessen, F., Pantel, J., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02461-0 · Cited by 32
Villemagne, V. L., & Rowe, C. C. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000895 · Cited by 30
Suon, S., Zhao, J. J., Villarreal, S. A., Anumula, N., Liu, M., Carangia, L. M., Renger, J. J., & Zerbinatti, C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-44 · Cited by 31
Sexual dimorphism of frailty and cognitive impairment: Potential underlying mechanisms
Ruan, Q., D’Onofrio, G., Wu, T., Greco, A., Sancarlo, D., & Yu, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6988 · Cited by 30
Falcón, C., Tucholka, A., Monté, G. C., Cacciaglia, R., Operto, G., Rami, L., Gispert, J. D., & Molinuevo, J. L. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.016 · Cited by 29
Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease
Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Graff‐Radford, J., Ertekin‐Taner, N., Machulda, M. M., Duffy, J. R., Schwarz, C. G., Senjem, M. L., Jack, C. R., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.012 · Cited by 29
1 H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
Nedelská, Z., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Lowe, V. J., Machulda, M. M., Kremers, W. K., Mielke, M. M., Roberts, R. O., Boeve, B. F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004421 · Cited by 29
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Vila‐Castelar, C., Akinci, M., Palpatzis, E., Dominguez, P. A., Operto, G., Kollmorgen, G., Quijano‐Rubio, C., Blennow, K., Zetterberg, H., Falcón, C., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02753-9 · Cited by 32
Factors Influencing Alzheimer’s Disease Risk: Whether and How They are Related to the APOE Genotype
Zhang, R., Xu, X., Yu, H., Xu, X., Wang, M., & Le, W. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-021-00814-5 · Cited by 31
Spinelli, G., on behalf of the INSIGHT-preAD Study Group, Bakardjian, H., Schwartz, D., Potier, M., Habert, M., Lévy, M., Dubois, B., & George, N. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220204 · Cited by 32
Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease
Johnson, C. E., Duncan, M. J., & Murphy, M. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230527 · Cited by 34
Recent insights into the cellular and molecular determinants of aging
Ruan, L., Zhang, X., & Li, R. (2018) · Journal of Cell Science · doi:10.1242/jcs.210831 · Cited by 28
Influence of APOE genotype in primary age-related tauopathy
Robinson, A., Davidson, Y. S., Roncaroli, F., Minshull, J., Tinkler, P., Horan, M. A., Payton, A., Pendleton, N., & Mann, D. M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01095-1 · Cited by 27
Pfeil, J., Hoenig, M. C., Doering, E., van Eimeren, T., Drzezga, A. E., & Bischof, G. N. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.014 · Cited by 27
Vila‐Castelar, C., Tariot, P. N., Sink, K. M., Clayton, D., Langbaum, J. B. S., Thomas, R. G., Chen, Y., Su, Y., Chen, K., Hu, N., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12552 · Cited by 27
Huang, Y., Ma, Y., Gao, P., Wang, Z., Huang, L., Hou, J., Tan, L., & Yu, J. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01217-6 · Cited by 29
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Stella, F., & Gattaz, W. F. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-3505 · Cited by 31
Rajabli, F., Benchek, P. H., Tosto, G., Kushch, N. A., Sha, J., Bazemore, K., Zhu, C., Lee, W., Haut, J., Hamilton‐Nelson, K. L., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03564-z · Cited by 44
Natunen, T., Martiskainen, H., Sarajärvi, T., Helisalmi, S., Pursiheimo, J., Viswanathan, J., Laitinen, M. H., Mäkinen, P. M., Kauppinen, T., Rauramaa, T. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080700 · Cited by 26
Knopman, D. S., Jack, C. R., Lundt, E. S., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.003 · Cited by 27
Lin, S.-Y., Lin, K., Lin, P.-C., Huang, C.-C., Chang, C., Lee, Y., Hsiao, I., Yen, T., Huang, W.-S., Yang, B., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0566-0 · Cited by 26
Hsieh, Y., Negri, J. M., He, A., Pearse, R. V., Liu, L., Duong, D. M., Chibnik, L. B., Bennett, D. A., Seyfried, N. T., & Young‐Pearse, T. L. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00558-4 · Cited by 25
Hosokawa, C., Ishii, K., Kimura, Y., Hyodo, T., Hosono, M., Sakaguchi, K., Usami, K., Shimamoto, K., Yamazoe, Y., & Murakami, T. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156414 · Cited by 26
New Genes and New Insights from Old Genes
Ringman, J. M., & Coppola, G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429179.21977.a1 · Cited by 27
Aging and Apolipoprotein E in HIV Infection
Geffin, R., & McCarthy, M. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0660-2 · Cited by 29
Pignataro, A., Meli, G., Pagano, R., Fontebasso, V., Battistella, R., Conforto, G., Ammassari‐Teule, M., & Middei, S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.10.018 · Cited by 27
Shared Genetic Risk Factors for Late-Life Depression and Alzheimer’s Disease
Ye, Q., Bai, F., & Zhang, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151129 · Cited by 26
Ahmad, S., Orellana, A., Köhler, I., Frölich, L., de Rojas, I., Gil, S., Boada, M., Hernández, I., Hausner, L., Bakker, M. H. M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00680-9 · Cited by 27
Hu, H., Tan, L., Bi, Y., Xu, W., Tan, L., Shen, X., Hou, X., Ma, Y., Dong, Q., & Yu, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01218-9 · Cited by 25
Yasuno, F., Kazui, H., Morita, N., Kajimoto, K., Ihara, M., Taguchi, A., Yamamoto, A., Matsuoka, K., Kosaka, J., Kudo, T., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4235 · Cited by 25
Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes
Frey, K. A., & Petrou, M. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0104-4 · Cited by 27
A Computerized Continuous-Recognition Task for Measurement of Episodic Memory
Ashford, J. W., Tarpin-Bernard, F., Ashford, C. B., & Ashford, M. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190167 · Cited by 25
Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries
Xu, X., Kwon, J., Yan, R., Apio, C., Song, S. C., Heo, G., Yang, Q., Timsina, J., Liu, M., Budde, J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0562 · Cited by 30
Self-citationΒ-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review
Chung, J. K., Nakajima, S., Plitman, E., Iwata, Y., Uy, D., Gerretsen, P., Caravaggio, F., Chakravarty, M. M., & Graff‐Guerrero, A. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.03.013 · Cited by 24
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
Joseph‐Mathurin, N., Su, Y., Blazey, T., Jasielec, M. S., Vlassenko, A. G., Friedrichsen, K. A., Gordon, B. A., Hornbeck, R. C., Cash, L. A., Ances, B. M., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.08.012 · Cited by 26
Self-citationAssociations Between APOE Variants, Tau and α-Synuclein
Rodriguez‐Vieitez, E., & Nielsen, H. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_15 · Cited by 24
Ma, Y., Wu, J., Xu, W., Shen, X., Wang, H.-F., Hou, X., Cao, X., Bi, Y., Dong, Q., Feng, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200410 · Cited by 24
Li, S., the DELCODE Study Group, Daamen, M., Scheef, L., Gaertner, F. C., Buchert, R., Buchmann, M., Büerger, K., Catak, C., Dobisch, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200472 · Cited by 25
Bilingualism as a Contributor to Cognitive Reserve: What it Can do and What it Cannot do
Berkes, M., & Bialystok, E. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221091417 · Cited by 26
Andersson, E., Schultz, N., Saito, T., Saido, T. C., Blennow, K., Gouras, G. K., Zetterberg, H., & Hansson, O. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01196-8 · Cited by 26
Cuesta, P., Barabash, A., Aurtenetxe, S., Garcés, P., López, M. E., Bajo, R., Luque, M. L., Ancín, I., Cabranes, J. A., Marcos, A., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140633 · Cited by 25
Valkanova, V., & Ebmeier, K. P. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.016 · Cited by 27
Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds
Loehrer, E. A., Ikram, M. A., Akoudad, S., Vrooman, H. A., van der Lugt, A., Niessen, W. J., Albert Hofman, D., & Vernooij, M. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.012 · Cited by 24
Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network
Initiative, T. A. D. N., Jin, Y., Su, Y., Zhou, X., & Huang, S. (2016) · EURASIP Journal on Bioinformatics and Systems Biology · doi:10.1186/s13637-016-0046-9 · Cited by 25
Brookmeyer, R., & Abdalla, N. (2019) · Clinical Trials · doi:10.1177/1740774518816323 · Cited by 24
Cognitive Profiling Related to Cerebral Amyloid Beta Burden Using Machine Learning Approaches
Ko, H., Ihm, J., Kim, H., & Initiative, A. D. N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00095 · Cited by 24
Neuroprotective Effects of the FGF21 Analogue LY2405319
Rühlmann, C., Dannehl, D., Brodtrück, M., Adams, A. C., Stenzel, J., Lindner, T., Krause, B. J., Vollmar, B., & Kuhla, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200837 · Cited by 24
Metadata
- Authors
- Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Morris, John C.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 67
- Issue
- 1
- Pages
- 122-131
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2830375
- OpenAlex
- W2014897304
- Cited by
- 830
- References
- 80
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 38 · 2023: 39 · 2022: 54 · 2021: 40 · 2020: 53 · 2019: 53 · 2018: 49 · 2017: 58 · 2016: 54 · 2015: 48 · 2014: 65 · 2013: 76 · 2012: 63
- FWCI
- 32.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000448)
- National Institute on Aging (P50AG005681, P01AG003991, P01AG026276)
- National Center for Research Resources (UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- apolipoprotein E, APOE ε4, APOE2, amyloid-beta, tau protein, preclinical Alzheimer's disease, Pittsburgh compound B, cerebrospinal fluid biomarkers, gene dosage effect, phosphorylated tau
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Aniline Compounds, Apolipoproteins E, Brain, Female, Follow-Up Studies, Genotype, Humans, Longitudinal Studies, Male, Middle Aged, Peptide Fragments, Phosphorylation, Thiazoles, Amyloid beta-Peptides, tau Proteins, Apolipoprotein E4, Apolipoprotein E2, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
